CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring

Patent ExpiryNu.Q® NETs TestPositive
AI Analysis

Summary

VolitionRx filed a new patent protecting its Nu.Q® NETs Test for Ebola triage and treatment monitoring while seeking strategic partners to deploy the platform in outbreak zones.

Outcome Details

New patent filed protecting Nu.Q® NETs Test

Importance:4/10
Sentiment:
0.30
intellectual propertypatent filingdiagnostic testepigeneticsEbolastrategic partnerships
Related Companies
$VNRX

Read the original article

Published by PR Newswire Pharma on June 3, 2026 12:12 PM

Read Original